← FDA Drug Approvals (Drugs@FDA)

STIMUFEND

BLA · Biologics License Application · Sponsor: FRESENIUS KABI USA · Approved 2022-09-01

Drug application

FDA Application #

BLA761173

Application type

Biologics License Application

Brand name

STIMUFEND

Generic name

PEGFLILGRASTIM-FPGK

Active ingredients

PEGFILGRASTIM-FPGK

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2022-09-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown